GSK initiates Phase III trial of eltrombopag-azacitidine combination in MDS patients

GlaxoSmithKline (GSK) has initiated a Phase III trial, SUPPORT (TRC112121), of eltrombopag in patients with myelodysplastic syndromes (MDS), a type of cancer.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news